LNSR

LENSAR, Inc.

Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001320350 Healthcare & Medical Devices

$5.98 −0.09 (−1.48%)

Oct 26 4:00 PM ET · prev $6.07

Market cap

$74.0M

Micro cap

Consensus

Buy

89% Buy or better · 9 analysts

Median target

$11.00

+84% · range $10.00–13.00

Next earnings

Nov 5

in 10 days · EPS est. −$0.14

1 year

−49.6%

from $11.86 · Oct 27

30 days

−13.1%

from $6.88

52-week range

$5.01–12.73

−53% from high · low Jul 31

Avg volume 20D

45.1K

Oct 22 spike 163.2K

Short interest

322.4K

≈2.6% of shares · −4.7%

Days to cover

6.6

at average volume

Insider net

no open-market trades · 12 mo

New fund stakes

Q2 2026 13F · 0 exits

SecBot read MIXED 2 reports · 90 days

Balance 1 bearish · 1 bullish oldest → newest, height = score

Avg score

·High conf. 1/2 ·Next Earnings date, Nov 5, 2026

Strongest BEARISH A significant institutional cluster in LENSAR (LNSR) shows 12 sellers reducing positions by $4.7M net vs 5…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

InsidersNO TRADES

No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
InstitutionsBEARISH

Q2 2026: 5 added (0 new), 12 trimmed or exited.
AnalystsBULLISH

8 of 9 rate it Buy or better. Every target is above the price.
EstimatesRISING

Current-quarter EPS estimate −$0.220 → −$0.140 over 90 days.
Short sellersSTEADY

Short interest −4.7% to 322.4K shares. 6.6 days to cover, ≈2.6% of shares.
TrendDOWNTREND

18% below its 50-day average.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
BlackRock, Inc.	TRIM	185,033	$1.1M
DIMENSIONAL FUND ADVISORS LP	TRIM	151,609	$865.7K
MILLENNIUM MANAGEMENT LLC	DOUBLED	120,680	$689.1K
GEODE CAPITAL MANAGEMENT, LLC	TRIM	114,331	$653.2K
STATE STREET CORP	TRIM	80,983	$462.4K
GOLDMAN SACHS GROUP INC	TRIM	59,529	$339.9K
Cresset Asset Management, LLC	ADD	25,000	$142.8K
NORTHERN TRUST CORP	TRIM	22,017	$125.7K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

9 analysts

Buy 89% rate it Buy or better

Strong Buy3Buy5Hold1Sell0Strong Sell0

12-month targets · 3 analysts

$5.98 $10.00 $11.00 $13.00

Price is below the lowest target. Median implies +84%.Targets as of Oct 26, 2026.

Recent actions

Date	Firm	Action	Rating
Sep 28, 2026	LUCID CAPITAL MARKETS INITIATE	INITIATE	Buy
Aug 20, 2026	BTIG MAINTAIN	MAINTAIN	Buy
Aug 13, 2026	BTIG MAINTAIN	MAINTAIN	Buy

Insider ledger

Form 4

open-market buys or sells · 12 mo

Date	Insider	Type	Value
Jun 3, 2026	O'Farrell Elizabeth G. Director	AWARD	17,421 sh
Jun 3, 2026	LINDSTROM RICHARD L MD Director	AWARD	17,421 sh
Jun 3, 2026	CURTIS NICHOLAS T Chief Executive Officer	AWARD	130,662 sh
Jun 3, 2026	Winer Gary M Director	AWARD	17,421 sh
Jun 3, 2026	WEISNER AIMEE S Director	AWARD	17,421 sh
Jun 3, 2026	Connaughton Alan B. Chief Operating Officer	AWARD	34,843 sh
Jun 3, 2026	Wong Kendra Principal Accounting Officer	AWARD	13,066 sh
Jun 3, 2026	LINK WILLIAM J PHD Director	AWARD	17,421 sh

Earnings setup

Estimates

Nov 5

reports in 10 days

−$0.14

EPS estimate, this quarter

+36%

estimate change, 90 days

Current-quarter EPS estimate

−$0.220

90d

−$0.220

60d

$0.000

30d

$0.000

−$0.140

Now

Period	EPS est.	Range	30D rev.	Revenue
Current Q	-$0.14	-$0.14–-$0.14	—	$14.3M
Next Q	-$0.10	-$0.10–-$0.10	—	$17.1M
Current FY	-$0.05	-$0.05–-$0.05	—	$61.3M
Next FY	-$0.51	-$0.51–-$0.51	—	$72.8M